MedXY – Page 9 – Medxy AI

Clinical Updates OB/GYN & Women's Health

Intraoperative Iodine Staining During LEEP: A Randomized Trial Challenging Its Routine Use

By MedXY 11/03/2026

A randomized trial shows that intraoperative Lugol’s iodine staining during LEEP increases positive resection margins and should not be routinely applied, despite reducing postoperative bleeding duration.

Clinical Updates Gastroenterology

Dietary Intervention Lowers Intestinal Inflammation in High-Risk Relatives of Crohn’s Disease Patients: Insights from the PIONIR Trial

By MedXY 11/03/2026

The PIONIR randomized crossover trial demonstrates that a specific Tasty&Healthy diet significantly reduces fecal calprotectin levels, a marker of gut inflammation, in first-degree relatives at high risk for Crohn's disease, suggesting potential for dietary prevention.

Clinical Updates Neurology Psychiatry

Self-Guided Internet-Based Therapy Significantly Reduces Functional Seizures: Insights from a Randomized Clinical Trial

By MedXY 11/03/2026

A randomized clinical trial demonstrates that a self-guided internet intervention significantly reduces seizure frequency and improves anxiety in adults with functional seizures, offering a scalable treatment alternative to standard care.

Clinical Updates Diabetes & Endocrinology Nephrology

Comparative Effectiveness of Semaglutide versus Dulaglutide or Liraglutide in Hemodialysis Patients with Diabetes

By MedXY 11/03/2026

This study evaluates semaglutide's benefits over dulaglutide or liraglutide among diabetic hemodialysis patients, highlighting improved survival, reduced hospitalizations, and greater weight loss with semaglutide.

Cardiology Clinical Updates

Modulating Coronary Artery Calcification Progression: Insights from the DANCODE Trial on Vitamin K2 and D3 Supplementation

By MedXY 11/03/2026

The DANCODE trial demonstrates that combined vitamin K2 and D3 supplementation reduces the progression of severe coronary artery calcification over 24 months without increasing noncalcified plaque burden, offering a promising adjunctive strategy in cardiovascular risk management.

Clinical Updates Orthopedics

Evaluating the Global Track Concept in Anterior Shoulder Instability with Glenohumeral Bone Loss: Implications for Clinical Decision-Making

By MedXY 11/03/2026

This study assesses the global track measurement against traditional imaging metrics to better predict engagement risk in anterior shoulder instability due to bipolar bone loss, highlighting its potential and need for further validation.

Clinical Updates Neurology Nursing & care

Evaluating Rehabilitation Outcomes: Inpatient Rehabilitation Facilities Versus Skilled Nursing Facilities Post-Acute Stroke

By MedXY 11/03/2026

This study compares the effectiveness of inpatient rehabilitation facilities and skilled nursing facilities on functional recovery after acute stroke, showing inpatient care offers greater long-term home time.

Clinical Updates Oncology Otorhinolaryngology

Oral Irrigation Enhances Microbiome Stability and Recovery After Oral Cancer Reconstruction

By MedXY 11/03/2026

Surgical trauma from oral cancer reconstruction disrupts oral microbiota; staged oral irrigation, especially using bipolar water, supports microbial stabilization, lowers fungal presence, and improves patient comfort, aiding postoperative recovery.

KRAS G12C 突变 NSCLC 中 Divarasib 与 Sotorasib、Adagrasib 的比较：临床与转化医学综合综述

Clinical Updates Oncology

Divarasib Compared with Sotorasib and Adagrasib in KRAS G12C-Mutated NSCLC: A Comprehensive Clinical and Translational Review

By MedXY 11/03/2026

This review synthesizes phase 3 clinical evidence comparing divarasib, sotorasib, and adagrasib for KRAS G12C-mutated NSCLC, highlighting divarasib's superior efficacy and safety, dose optimization insights, real-world data, and translational biomarker findings.

Clinical Updates Orthopedics

Early Controlled Mobilisation in Radial Head Fractures Enhances Recovery Without Clinically Significant Differences

By MedXY 11/02/2026

A multicentre retrospective study shows early controlled mobilisation in nonoperatively treated Mason type I and II radial head fractures leads to modest improvements in function, pain, and return to work times, with no significant increase in complications over delayed rehabilitation.

Clinical Updates Dentistry Orthopedics

Innovative Polyurethane Resin Cement with Dual Antibacterial Mechanisms for Enhanced Secondary Caries Prevention

By MedXY 11/02/2026

A novel polyurethane resin cement incorporating 3% DMAHDM exhibits potent antibacterial effects, maintains strong mechanical properties, and offers promising dual-action caries prevention for indirect restorations.

复发型多发性硬化治疗再添新证据：REMODEL-1 与 REMODEL-2 Ⅲ期试验显示 remibrutinib 优于 teriflunomide

Clinical Updates Neurology

Remibrutinib Demonstrates Superior Efficacy and Safety over Teriflunomide in Relapsing Multiple Sclerosis: Insights from REMODEL-1 and REMODEL-2 Phase 3 Trials

By MedXY 11/02/2026

Two phase 3 trials establish remibrutinib, a BTK inhibitor, as more effective and better tolerated than teriflunomide in relapsing multiple sclerosis, supporting its potential as a new oral treatment.

小児科GMEにおける擁護教育を標準化する新枠組み：Community Pediatrics & Advocacy Curriculum

Clinical Updates Pediatrics

The Community Pediatrics & Advocacy Curriculum: Standardizing Advocacy Education in Pediatric Graduate Medical Education

By MedXY 11/02/2026

A concise guide to the new AAP-endorsed curriculum framework that standardizes advocacy training in pediatric residency and fellowships using a socioecological model and practical, competency-linked tools for graduate medical education.

Clinical Updates Rheumatology

Sustained Remission and Long-Term Success: A Decade of Treat-to-Target Therapy in Early Rheumatoid Arthritis

By MedXY 11/02/2026

A 10-year follow-up of early rheumatoid arthritis patients treated with a treat-to-target strategy shows sustained remission leads to lasting clinical, structural, and functional benefits, supporting current treatment guidelines.

Clinical Updates Nephrology Transplantation

Impact of Kidney Allocation Policy Reforms and Donor Hospital Geography on Utilization of Deceased Donor Kidneys

By MedXY 11/02/2026

Recent large-cohort analyses reveal that donor hospital distance from OPO headquarters does not increase deceased donor kidney nonuse, while policy changes like KAS250 temporarily raise nonuse rates but overall kidney utilization continues to improve.

Clinical Updates Dermatology OB/GYN & Women's Health

Safety of Biologic Therapy in Pregnancy for Psoriasis Patients: Insights from a Large Cohort Study

By MedXY 11/02/2026

This large cohort study demonstrates that biologic therapy in pregnant women with psoriasis is not associated with increased adverse pregnancy outcomes and may reduce risks of spontaneous abortion and gestational diabetes.

Clinical Updates Plastic Surgery

Innovative Internal Hemostatic Network Dramatically Reduces Postoperative Hematoma After Facelift Surgery: Analysis of 561 Cases

By MedXY 11/02/2026

A composite internal stabilization strategy using an internal hemostatic network significantly reduced postoperative hematoma incidence to zero in 356 facelift procedures, compared to 5.9% with conventional methods, enabling safer recovery without drains or compression.

Clinical Updates Critical Care Pediatrics

Reducing Cardiac Arrest during Pediatric Tracheal Intubation: Insights from the National Emergency Airway Registry

By MedXY 11/02/2026

An analysis of 27,773 pediatric tracheal intubations reveals 1.2% associated cardiac arrest, highlighting preventable factors such as multiple intubation attempts and benefits linked to video laryngoscopy and specific medications.

Clinical Updates Family Medicine & Nutrition Internal Medicine

Barriers and Opportunities in Medicare Advanced Primary Care Management Billing: Early Uptake Insights

By MedXY 11/02/2026

Despite substantial potential revenue, only 15% of US primary care clinicians adopted Medicare's Advanced Primary Care Management codes in 2025, with administrative challenges as key barriers.

镰状细胞病卒中预防中羟基脲固定低剂量与中剂量的长期结局：SPRINT队列研究解读

Clinical Updates Hematology-Oncology Neurology

Long-Term Outcomes of Fixed Low versus Moderate Hydroxyurea Dosing in Sickle Cell Stroke Prevention: Insights from the SPRINT Cohort

By MedXY 11/02/2026

A long-term follow-up of the SPRINT trial shows no significant difference in recurrent stroke or mortality rates between initial low and moderate fixed doses of hydroxyurea in sickle cell disease, emphasizing event clustering within the first year.